Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Amber LED photobiomodulation versus tranexamic acid for the treatment of melasma: randomized controlled double-blind pilot trial

Although no significant clinical changes were detected in MASI or PGA, both treatments improved the quality of life, highlighting the importance of patient-reported outcomes.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

In this small randomized pilot trial of 21 women with melasma, the authors compared amber light therapy with placebo cream against sham light therapy with tranexamic acid cream over 12 weeks. They report no significant differences in MASI or PGA scores, but both groups improved in quality of life, and the study was underpowered due to early termination.

Participants
21
Who or what was studied
Women with melasma
Limits stated in the abstract
The study was underpowered (51% power) due to early termination and small sample size, and environmental temperatures during the study period may have confounded results.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Light-emitting diode, Randomized controlled trial, Trial registration, Primary outcome, Sample size, Sham. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies